FDA Inspection 1060487 — Baxter Deutschland GmbH
The FDA completed an inspection of Baxter Deutschland GmbH on June 14, 2018 in Bielefeld. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bielefeld (Germany)